Title : The development, safety and efficacy of pacritinib for the treatment of myelofibrosis.

Pub. Date : 2016 Nov

PMID : 27598824






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Areas covered: We discuss the various preclinical and clinical studies describing pacritinib, a selective JAK2/FLT3 inhibitor. 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene fms related receptor tyrosine kinase 3 Homo sapiens